1999
PA Consulting Group and Phase Forward in joint development and marketing agreement
-
18 October 1999
PA Consulting Group, the management, systems and technology consultancy, announced today that it has entered into a joint development and marketing agreement with Phase Forward Incorporated, the leading provider of web-based solutions for clinical trials. Under this agreement, PA will provide systems integration and business process consulting in situations where Phase Forward products are being implemented across the enterprise. The agreement includes providing joint marketing, product development and support initiatives to pharmaceutical, medical device and biotechnology companies striving to accelerate their clinical trial processes and product development capabilities.
"Web-based data collection and management will revolutionise the way companies carry out clinical development. The associated changes in development departments, business processes and organisations will be profound," said Dr Keith Redpath, a Member of PA's Management Group and Leaderhead of PA's Pharmaceutical Consulting Business.
"This is a great opportunity for PA," continued Dr Redpath. "There is a great deal of synergy between PA and Phase Forward, most notably providing highly automated data collection and analysis, supported by an information management infrastructure and tight relationships with external providers. We are pleased to be working with a company with whom we share such a clear vision of the future."
"PA Consulting's proven model for educating and helping companies fits well with Phase Forward's philosophy of helping customers change," commented Dr. Paul Bleicher, Chief Scientific Officer of Phase Forward. "PA's experience and global reach combined with Phase Forward technology will give customers confidence in their decision to adopt new clinical trial technology and a positive understanding of the impact on their organisation."
Dr Redpath concluded: "The nature of the traditional R&D-based pharmaceutical company over the next decade will change fundamentally, as the role of IT becomes increasingly central to the success of a pharmaceutical company. The PA/Phase Forward partnership offers companies the technology and business consulting support to address the issues they face as the biomedical industry shifts its focus to knowledge engineering."
For more information, please contact:
|
| Dr Adam Adams |
| PA Consulting Group |
| 123 Buckingham Palace Road |
| London |
| SW1W 9SR |
| United Kingdom |
|
|
Tel: +44 20 7312 4602 |
|
Fax: +44 20 7312 4639 |
|
E-mail:
adam.adams@paconsulting.com |
|
|
|
Notes to editors
PA Consulting Group is a leading management, systems and technology consultancy, with a unique commitment to the integration of these capabilities. Established almost 60 years ago, and operating world-wide from around 50 offices in some 20 countries, PA draws on the knowledge and experience of about 2,700 employees, whose skills span the initial generation of ideas and insights all the way through to detailed implementation, including:
- Strategic management, and managing for shareholder value
- Accelerating business growth, especially through innovation
- Improving business design, including customer relationship management, enterprise-wide systems for the supply chain, and full e-business solutions
- Mobilising human resources
- Delivering projects and programmes
PA focuses on creating benefits for clients rather than merely proposing them, and this focus is supported by an outstanding implementation track record in every major industry and for governments around the world. PA also develops leading edge technology both for its clients and within its own portfolio of venture companies in areas ranging from software to wireless technology to life sciences.
PA distinguishes itself from its competitors through the range and quality of its people, its development and use of technology, and also its independence. PA's work in every area from strategic management to project delivery is enhanced by its expertise in all the other areas. PA's consultants, whatever their special skills, all share:
- a highly commercial approach to clients' problems and opportunities
- a technologically sophisticated view of both the industry sectors we serve and the solutions we deliver
- a culture of respect, collaboration and flexibility in working with our clients to achieve their aims
Adding value to clients, from insight to implementation, is ingrained at PA through our culture and tradition, and also through our compensation and ownership philosophy. PA is owned by its employees, with everyone at PA entitled to a stake in the company, and our reward systems are also directly related to the results created for clients. This builds a virtuous circle, as we know that the only way we can create value for ourselves is by creating value for our clients first. The value we create for clients and within PA helps us to attract the best people in the world to PA, and to invest in more leading edge technologies, thereby allowing us to increase further the value we bring to our clients. We are proud that our clients say "PA makes it happen"
Phase Forward is a leader in the emerging drug development automation market, focused on Web-based clinical trials of new drugs and devices. Phase Forward's InForm uses Internet technologies to conduct and manage clinical trials efficiently and effectively. Our software and service solutions allow sponsors of clinical trials to eliminate the need to transcribe and process traditional paper data forms, to access global clinical trial data in real-time, and to begin data analysis almost immediately after the last patient has visited the clinic. Clinical trial sponsors can cut 1-2 years off the current 7-9 years that it takes to bring new drugs to market enabling them to maximize their revenue potential. Phase Forward Incorporated, a privately held company, is headquartered in Waltham, MA. For more information, visit Phase Forward at www.phaseforward.com.
|
